Cheng-Hui Yan (Chenghui Yan)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 14

Top Topics

Randomized Controlled Trial

Vascular Smooth Muscle Cells

Cardiovascular Risk Factors

Top Venues

Cell death & disease

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Xiaodong Jia, Zheming Yang, Jiayin Li, Zhu Mei, Lihui Jia, Cheng-Hui Yan
The impact of biologic agents on cardiovascular risk factors in patients with rheumatoid arthritis: A meta analysis. PloS one 19 (8) (2024)
Xiaodong Jia, Zheming Yang, Jiayin Li, Zhu Mei, Lihui Jia, Cheng-Hui Yan
The impact of biologic agents on cardiovascular risk factors in patients with rheumatoid arthritis: A meta analysis. PloS one 19 (8) (2024)
Bing Yan, Zhu Mei, Yaohan Tang, Haixu Song, Hanlin Wu, Quanmin Jing, Xiaolin Zhang, Cheng-Hui Yan, Ya-Ling Han
FGF21-FGFR1 controls mitochondrial homeostasis in cardiomyocytes by modulating the degradation of OPA1. Cell death & disease 14 (5) (2023)
Zheming Yang, Xiaodong Jia, Jiayin Li, Zhu Mei, Lin Yang, Cheng-Hui Yan, Ya-Ling Han
Efficacy and Safety of Hybrid Comprehensive Telerehabilitation (HCTR) for Cardiac Rehabilitation in Patients with Cardiovascular Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Occupational therapy international 2023 (2023)
Bing Yan, Zhu Mei, Yaohan Tang, Haixu Song, Hanlin Wu, Quanmin Jing, Xiaolin Zhang, Cheng-Hui Yan, Ya-Ling Han
FGF21-FGFR1 controls mitochondrial homeostasis in cardiomyocytes by modulating the degradation of OPA1. Cell death & disease 14 (5) (2023)
Bing Yan, Zhu Mei, Yaohan Tang, Haixu Song, Hanlin Wu, Quanmin Jing, Xiaolin Zhang, Cheng-Hui Yan, Ya-Ling Han
FGF21-FGFR1 controls mitochondrial homeostasis in cardiomyocytes by modulating the degradation of OPA1. Cell death & disease 14 (5) (2023)
Bing Yan, Zhu Mei, Yaohan Tang, Haixu Song, Hanlin Wu, Quanmin Jing, Xiaolin Zhang, Cheng-Hui Yan, Ya-Ling Han
FGF21-FGFR1 controls mitochondrial homeostasis in cardiomyocytes by modulating the degradation of OPA1. Cell death & disease 14 (5) (2023)
Cheng-Hui Yan, Hai-Wei Liu, Xiao-Xiang Tian, Jiayin Li, Ye Ding, Yi Li, Zhu Mei, Ming-Hui Zou, Ya-Ling Han
AMPKα2 controls the anti-atherosclerotic effects of fish oils by modulating the SUMOylation of GPR120. Nature communications 13 (1) (2022)
Cheng-Hui Yan, Hai-Wei Liu, Xiao-Xiang Tian, Jiayin Li, Ye Ding, Yi Li, Zhu Mei, Ming-Hui Zou, Ya-Ling Han
AMPKα2 controls the anti-atherosclerotic effects of fish oils by modulating the SUMOylation of GPR120. Nature communications 13 (1) (2022)
Cheng-Hui Yan, Hai-Wei Liu, Xiao-Xiang Tian, Jiayin Li, Ye Ding, Yi Li, Zhu Mei, Ming-Hui Zou, Ya-Ling Han
AMPKα2 controls the anti-atherosclerotic effects of fish oils by modulating the SUMOylation of GPR120. Nature communications 13 (1) (2022)
Jia Li, Cheng-Hui Yan, Yilong Wang, Can Chen, Haibo Yu, Dan Liu, Kai Huang, Ya-Ling Han
GCN5-mediated regulation of pathological cardiac hypertrophy via activation of the TAK1-JNK/p38 signaling pathway. Cell death & disease 13 (4) (2022)
Cheng-Hui Yan, Hai-Wei Liu, Xiao-Xiang Tian, Jiayin Li, Ye Ding, Yi Li, Zhu Mei, Ming-Hui Zou, Ya-Ling Han
AMPKα2 controls the anti-atherosclerotic effects of fish oils by modulating the SUMOylation of GPR120. Nature communications 13 (1) (2022)
Dan Liu, Xiaoxiang Tian, Yanxia Liu, Haixu Song, Xiaoli Cheng, Xiaolin Zhang, Cheng-Hui Yan, Ya-Ling Han
CREG ameliorates the phenotypic switching of cardiac fibroblasts after myocardial infarction via modulation of CDC42. Cell death & disease 12 (4) (2021)
Cheng-Hui Yan, Jiayin Li, Dan Liu, Ding Ye, Zhonglin Xie, Yaling Han, Ming-Hui Zou
A High-Fat Diet Attenuates AMPK α1 in Adipocytes to Induce Exosome Shedding and Nonalcoholic Fatty Liver Development In Vivo. Diabetes 70 (2) (2020)